{
  "meta": {
    "title": "Normal_Development_Structure_And_Function",
    "url": "https://brainandscalpel.vercel.app/normal-development-structure-and-function-be282fd8.html",
    "scrapedAt": "2025-11-30T14:13:38.391Z"
  },
  "questions": [
    {
      "text": "<span>A 25-year-old woman, gravida 2, para 1, presents to the clinic for her first antenatal appointment at&#160;</span><span>6 weeks</span><span>&#160;of estimated gestational age</span><span>. She&#160;</span><span>is asymptomatic</span><span>&#160;and feels well</span><span>. Past medical history is notable for&#160;</span><span>sickle cell disease, managed with hydroxyurea, as well as an uncomplicated vaginal delivery&#160;</span><span>two</span><span>&#160;years ago.&#160;</span><span>Temperature is 36.9&#176;C (98.4&#176;F), pulse is 7</span><span>2</span><span>/min, respirations are 14/min, and blood pressure is 116/</span><span>74 mm</span><span>Hg.</span><span>&#160;</span><span>On&#160;</span><span>physical</span><span>&#160;</span><span>exam</span><span>,</span><span>&#160;the patient&#160;</span><span>is in no&#160;</span><span>distress</span><span>. The uterus is</span><span>&#160;</span><span>mildly&#160;</span><span>enlarged,</span><span>&#160;</span><span>and</span><span>&#160;</span><span>the</span><span>&#160;pelvis</span><span>&#160;</span><span>is normal</span><span>.&#160;</span><span>Screening</span><span>&#160;l</span><span>ab</span><span>oratory</span><span>&#160;results are shown&#160;</span><span>in the table&#160;</span><span>below</span><span>.&#160;</span><span>Which of&#160;</span><span>the following is the most&#160;</span><span>appropriate next</span><span>&#160;step in management?</span>&#160;<br><br><table><tbody><tr><td>&#160;<span><strong>Laboratory value</strong></span>&#160; &#160; &#160;</td><td><strong>&#160;<span>Result</span>&#160; &#160; &#160;</strong></td></tr><tr><td><strong>&#160;<span>Serum chemistries</span>&#160; &#160; &#160;</strong></td><td>&#160; &#160; &#160;&#160;</td></tr><tr><td>&#160;<span>Hemoglobin</span>&#160; &#160; &#160;</td><td>&#160;<span>10.1</span><span>&#160;</span><span>g</span><span>/dL</span>&#160; &#160; &#160;</td></tr><tr><td>&#160;<span>Hematocrit</span>&#160; &#160; &#160;</td><td>&#160;<span>31</span><span>&#160;%</span>&#160; &#160; &#160;</td></tr><tr><td>&#160;<span>Leukocyte count</span>&#160; &#160; &#160;</td><td>&#160;<span>7</span><span>,100 /mm</span><span>3</span>&#160; &#160; &#160;</td></tr><tr><td>&#160;<span>Platelet count</span>&#160; &#160; &#160;</td><td>&#160;<span>2</span><span>27</span><span>,000/mm</span><span>3</span>&#160; &#160; &#160;</td></tr><tr><td>&#160;<span>Mean corpuscular volume</span>&#160; &#160; &#160;</td><td>&#160;<span>7</span><span>7</span><span>&#160;</span><span>fL</span>&#160; &#160; &#160;</td></tr><tr><td>&#160;<span>Serum&#160;</span><span>ferritin</span>&#160; &#160; &#160;</td><td>&#160;<span>normal</span>&#160; &#160; &#160;</td></tr><tr><td>&#160;<span>Total-iron-binding&#160;</span><span>capacity</span>&#160; &#160; &#160;</td><td>&#160;<span>normal</span>&#160; &#160; &#160;</td></tr></tbody></table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><br>",
      "choices": [
        {
          "id": 1,
          "text": "High-dose folic acid supplementation"
        },
        {
          "id": 2,
          "text": "Iron supplementation"
        },
        {
          "id": 3,
          "text": "Increased hydroxyurea dose"
        },
        {
          "id": 4,
          "text": "Exchange transfusion"
        },
        {
          "id": 5,
          "text": "Iron chelation therapy"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/hqyxVOphTe_VSuOc07dUHduiTzWBjCpd/_.png\"></div><br><br><span>This&#160;</span><span>pregnant patient with</span><span>&#160;<strong>sickle cell disease</strong>&#160;</span><span>should be treated with&#160;</span><strong><span>high</span><span>-</span><span>dose folic acid supplementation</span></strong><span><strong>.</strong>&#160;</span><span>In patients with sickle cell disease</span><span>,</span><span>&#160;the abnormal hemoglobin, known as hemoglobin S (</span><span>HbS</span><span>)</span><span>,</span><span>&#160;</span><span>causes red blood cells to bend into an abnormal sickled shape that is easily destroyed.&#160;</span><span>To compensate,&#160;</span><strong><span>red cell production is increased</span><span>,</span></strong><span>&#160;which leads to<strong>&#160;</strong></span><span><strong>depletion of folic acid stores</strong></span><span>. Folic acid is critical for&#160;</span><span><strong>normal fetal development</strong></span><span>, especially early in gestation during development of the neural tube. For this reason, pregnant patients with&#160;</span><span><strong>SCD require high-dose folic acid supplementation</strong></span><span>&#160;during pregnancy.&#160;</span>&#160; &#160; &#160; &#160; <br><br><span>Hemoglobinopathies are associated with&#160;</span><span>multiple&#160;</span><span>increased risks during pregnancy.&#160;</span><span>Therefore,</span><span>&#160;</span><span>prenatal&#160;</span><span>management is more&#160;</span><span>intense</span><span>&#160;and&#160;</span><span>more&#160;</span><span>frequent</span><span>&#160;than when caring for non-affected individuals.</span><span>&#160;The risks and associated management recommendations for&#160;</span><span><strong>severe hemoglobinopathies</strong></span><span>&#160;are detailed in the table&#160;</span><span>above</span><span>.</span>&#160; &#160; &#160; &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ High-dose folic acid supplementation:</strong><br><span style='opacity:0.9'><span><strong>Correct: </strong></span><span>See Main Explanation.</span>&#160; &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Iron supplementation:</strong><br><span style='opacity:0.9'><strong><span>Incorrect:</span><span>&#160;</span></strong><span>Th</span><span>is</span><span>&#160;patient&#8217;s anemia is secondary to sickle cell disease</span><span>&#160;(SCD)</span><span>&#160;rather than iron deficiency anemia</span><span>,</span><span>&#160;given her known SCD and normal iron labs. She is at&#160;</span><span>greater&#160;</span><span>risk of transfusion-related iron overload rather than iron deficiency</span><span>&#160;and should not have supplemental iron.</span>&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Increased hydroxyurea dose:</strong><br><span style='opacity:0.9'><span><strong>Incorrect:</strong></span><span>&#160;</span><span>Hydroxyurea</span><span>&#160;</span><span>is teratogenic and can lead to congenital anomalies and pregnancy loss.&#160;</span><span>Instead of increasing the hydroxyurea dose,</span><span>&#160;the&#160;</span><span>risks</span><span>&#160;and benefits of decreasing&#160;</span><span>the dose&#160;</span><span>or&#160;</span><span>discontinuing</span><span>&#160;hydroxyurea should be discussed with the patient</span><span>&#160;at this time.</span>&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Exchange transfusion:</strong><br><span style='opacity:0.9'><span><strong>Incorrect:</strong></span><span>&#160;</span><span>An exchange transfusion may be&#160;</span><span>appropriate in</span><span>&#160;patients with sickle cell disease experiencing a pain crisis that does not respond to more conservative management. In an exchange transfusion, the abnormal sickled cells causing the&#160;</span><span>vasoo</span><span>c</span><span>clusions</span><span>&#160;are removed</span><span>&#160;while unaffected blood is transfused into the patient.</span><span>&#160;This patient is not having a pain crisis.</span>&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Iron chelation therapy:</strong><br><span style='opacity:0.9'><span><strong>Incorrect:</strong></span><span>&#160;</span><span>Iron chelation therapy is&#160;</span><span>indicated</span><span>&#160;in patients with severe&#160;</span><span>thalassemias</span><span>&#160;or</span><span>&#160;in patients with</span><span>&#160;</span><span>sickle cell disease who have&#160;</span><span>transfusion-related iron&#160;</span><span>overload.</span><span>&#160;</span><span>With</span><span>&#160;</span><span>thalassemias</span><span>, abnormal intracellular inclusions</span><span>&#160;of clumped excess globin chains</span><span>&#160;weaken the red cell membranes</span><span>,</span><span>&#160;</span><span>leading to intravascular hemolysis and iron overload.</span>&#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    }
  ]
}